Suppr超能文献

肺鳞状细胞癌的起源。增殖、DNA倍体和p53表达的序列变化。

Genesis of squamous cell lung carcinoma. Sequential changes of proliferation, DNA ploidy, and p53 expression.

作者信息

Hirano T, Franzén B, Kato H, Ebihara Y, Auer G

机构信息

Department of Tumor Pathology, Karolinska Institute, Stockholm, Sweden.

出版信息

Am J Pathol. 1994 Feb;144(2):296-302.

Abstract

Squamous cell lung carcinomas (SCCs) represent a highly malignant group of tumors, and effective treatment is greatly dependent upon early diagnosis. However, objective diagnosis of atypia is difficult and useful markers need to be defined. In this study, genomic instability, cell proliferation, and cellular accumulation of mutant p53, as reflected by DNA aneuploidy, proliferating cell nuclear antigen, and p53 immunoreactivity, respectively, were evaluated in bronchial squamous metaplasia without atypia (n = 4), bronchial squamous metaplasia with low-grade atypia (n = 12), bronchial squamous metaplasia with high-grade atypia (n = 15), early-stage SCC (n = 15), and advanced-stage SCC (n = 33). Our results suggest that hyperproliferation is an early event followed by DNA aneuploidy, which in turn precedes p53 immunoreactivity in the genesis of SCC. We conclude that routine assessment of proliferating cell nuclear antigen, DNA ploidy, and p53 may be valuable for the early diagnosis of SCC.

摘要

肺鳞状细胞癌(SCCs)是一类高度恶性的肿瘤,有效的治疗很大程度上依赖于早期诊断。然而,非典型性的客观诊断困难,需要确定有用的标志物。在本研究中,分别通过DNA非整倍体、增殖细胞核抗原和p53免疫反应性反映的基因组不稳定性、细胞增殖以及突变型p53的细胞蓄积,在无非典型性的支气管鳞状化生(n = 4)、低级别非典型性支气管鳞状化生(n = 12)、高级别非典型性支气管鳞状化生(n = 15)、早期SCC(n = 15)和晚期SCC(n = 33)中进行了评估。我们的结果表明,增殖过度是DNA非整倍体之前的早期事件,而DNA非整倍体又先于SCC发生过程中的p53免疫反应性。我们得出结论,对增殖细胞核抗原、DNA倍体和p53进行常规评估可能对SCC的早期诊断有价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac1a/1887133/f0bd285a1f96/amjpathol00062-0098-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验